Seroadaptive Strategies of Gay and Bisexual Men with the Highest Quartile Number of Sexual Partners in Vancouver, Canada

What is the importance of this study? Â¥ Recent global reviews of HIV research literature have demonstrated continued disparities in the sexual health and wellbeing of gay and bisexual men (GBM) as compared with other men and women. Â¥ One prominent factor associated with increased HIV risk is an individual’s number of sexual partners. Â¥ Despite continued research among this population, few studies have examined how men with more sexual partners manage their increased risk for HIV.

Citation: Kiffer G Card, Nathan J Lachowsky, Zishan Cui, Paul Sereda, Ashleigh Rich, Jody Jollimore, Terry Howard, Robery Birch, Allison Carter, Julio Montaner, David Moore, Robert S Hogg, & Eric Abella Roth. (2016) Seroadaptive Strategies of Gay & Bisexual Men (GBM) with the Highest Quartile Number of Sexual Partners in Vancouver, Canada, AIDS and Behavior, DOI 10.1007/s10461-016-1510-y.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below